Signal2026-07-07
ClinicalTrials.gov

[PHASE1] Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma

Part of

Cancer Immunotherapy And Combination Strategies

Open primary sourceSee the whole picture